Every life sciences organization needs to consider how best to apply machine learning (ML) to RWE to support better patient outcomes. Here’s how they can

Mark Cuban, co-founder of Cost Plus Drugs, and Linda Yaccarino, CEO of the employer GLP-1 platform eMed Population Health, were at SXSW drawing a contrast

Isaac Health launched an eight-week virtual program to help people reduce dementia risk through lifestyle changes like sleep, nutrition and exercise. The post Isaac Health

Leucovorin is now approved for cerebral folate deficiency months after FDA Commissioner Marty Makary claimed the decades-old generic drug had promise for treating autism. The

Epic has unveiled its new “agent factory,” a platform that lets health systems build AI agents that are capable of orchestrating entire workflows across the

Congress has already granted the FDA flexibility in evaluating therapies for rare diseases, including the use of real-world evidence and natural history data when traditional